(login)

Leading pharmaceutical
company in the Baltic States

Archive


2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
«Grindeks»: EU-funded Competence Centres Program is important to the development of Latvia’s national economy
07.02.2012
JSC «Grindeks» informs that the Company takes part in two EU-funded competence centres – “Pharma and Chemistry Competence Centre” and “Environment, Bioenergetics and Biotechnology Competence Centre”.

Read more


«Grindeks»: currently we have 20 new products under development
06.02.2012
«Grindeks» informs that it is currently developing 20 new products. Among these are the new combinations of Mildronate® and generics.

Read more


Juris Bundulis appointed as Chairman of the Board of JSC «Grindeks»
09.01.2012
Juris-Bundulis
JSC «Grindeks» informs that the Supervisory Council has appointed Mr. Juris Bundulis as Chairman of the Board of JSC «Grindeks».

Read more